Cisapride FDA Link

A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)

Also Known As:

Propulsid; R-51619; R 51619; R51619; Benzamide, 4- amino- 5- chloro- N- (1- (3- (4- fluorophenoxy)propyl)- 3- methoxy -4-piperidinyl)-2-methoxy-, cis-

Pharmalogical Action Categories:

Anti-Ulcer Agents
Gastrointestinal Agents
Serotonin Receptor Agonists

Organic Chemicals: 133
- Amides: 2428
  - Benzamides: 115
    - Cisapride: 696
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzoates: 426
        Benzamides: 115
        Cisapride: 696
        Aminobenzoates: 1
        para-Aminobenzoates: 43
        Cisapride: 696
        Chlorobenzoates
        Cisapride: 696
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Benzoates: 426
      - Benzamides: 115
        Cisapride: 696
      - Aminobenzoates: 1
        para-Aminobenzoates: 43
        Cisapride: 696
      - Chlorobenzoates
        Cisapride: 696
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - Cisapride: 696

G Kusenbach Selected Research

G Kusenbach Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure